ANGN - Angion Biomedica - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.192M

Cash

29.22M

Avg Qtr Burn

-7.704M

Short % of Float

0.25%

Insider Ownership

33.03%

Institutional Own.

16.37%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ANG-3777 (HGF mimetic) Details Acute respiratory distress syndrome	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANG-3070 (TKI) Details Focal segmental glomerulosclerosis, IgA nephropathy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANG-3777 (HGF mimetic) Details Acute Kidney Injury	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ANG-3777 (HGF mimetic) Details Acute Kidney Injury	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.